(Q36621336)

English

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?

scientific article published on 29 November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer? (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

chemoradiotherapy

0 references

author name string

Claire Vautravers Dewas

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Philippe Maingon

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cécile Dalban

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Aurélie Petitfils

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Karine Peignaux

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Gilles Truc

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Etienne Martin

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cédric Khoury

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sylvain Dewas

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Gilles Créhange

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

29 November 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Radiation Oncology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

201

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

30 September 2017

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

30 September 2017

Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

30 September 2017

Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

30 September 2017

Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

30 September 2017

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

30 September 2017

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

30 September 2017

Time-dose considerations in the treatment of anal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

28 June 2018

Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-201

21 January 2018

Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-201

21 January 2018

Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-201

21 January 2018

Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-201

21 January 2018

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-201

21 January 2018

Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-201

21 January 2018

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576273

20 September 2018

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/23190693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://pubmed.ncbi.nlm.nih.gov/23190693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23190693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal

1 reference

https://pubmed.ncbi.nlm.nih.gov/23190693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1748-717X-7-201

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36621336&oldid=2199106040"